22) IV iron is generally preferred over oral iron among #dialysis patients because it is more likely to ⬆️Hgb and ⬇️ESA dose. A meta-analysis showed that an ⬆️in Hgb by 1 g/dL was achieved by more participants in the IV iron group. 👉🏼🔓https://t.co/kuEa3MC
12/ Despite all the PO options, I.V. Iron replacement is more effective than P.O. Iron But It also showed significant side effects, with IV iron, like low BP and allergic reactions Link for article here: https://t.co/xQ75IuzalS https://t.co/Oa7Dvo4DKL
(NIHR) Tto de la ferropenia en pac con ERC por vía IV vs vía oral https://t.co/GE4CGC5yCP REC de Cochrane https://t.co/RzET9QUaDq Revisión original https://t.co/Iju8XFmOwQ
Nueva actualización de la Revisión Cochrane: terapia de hierro parenteral versus oral para adultos y niños con enfermedad renal crónica. https://t.co/ocuRTsUK9J
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
RT @CochraneKidney: New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Di…
New Cochrane Review update: Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Discover the latest #CochraneEvidence here: https://t.co/CFugyLtHlE #kidney #kidneydisease #CKD https://t.co/O2ueYFmajY
CKD患者において、鉄剤の静注は経口と比較して目標Hb値の達成人数の増加、Hb/フェリチン/TSATの上昇、ESA必要量の減少、消化器有害事象の減少がみられるかもしれない。 Parenteral versus oral iron therapy for adults and children with chronic kidney disease. https://t.co/ESk2dJlV2r
RT @EvidNutrition: #CochraneUpdate Terapia con hierro parenteral versus oral para adultos y niños con enfermedad renal crónica: https://t.c…
RT @EvidNutrition: #CochraneUpdate Terapia con hierro parenteral versus oral para adultos y niños con enfermedad renal crónica: https://t.c…
RT @EvidNutrition: #CochraneUpdate Terapia con hierro parenteral versus oral para adultos y niños con enfermedad renal crónica: https://t.c…
RT @EvidNutrition: #CochraneUpdate Terapia con hierro parenteral versus oral para adultos y niños con enfermedad renal crónica: https://t.c…
#CochraneUpdate Terapia con hierro parenteral versus oral para adultos y niños con enfermedad renal crónica: https://t.co/Pb268986mD Cc @cochranenutri @Cochraneiberoam @CochraneChile
Iron treatment for adults and children with reduced kidney function https://t.co/d0m09yhAf7 via @instapaper
Iron treatment for adults and children with reduced kidney function https://t.co/48bEajMJ0L